What's new? Log in Free sign up

Filing search / Cidara Therapeutics, Inc. / "Litigation"

Search information

Cidara Therapeutics, Inc.

Companies

"Litigation"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

142 results

Newest first Best match first

CDTX Cidara Therapeutics, Inc.

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe

CDTX Cidara Therapeutics, Inc.

; (p)significant changes in compensation policy; (q)bankruptcies or receiverships; (r)actual or threatened major litigation, or a major development … in or the resolution of such litigation; and (s)change in auditors or a notification that the Company can no longer rely on an auditor’s report

6 Mar 25

4:25pm

CDTX Cidara Therapeutics, Inc.

litigation; the initiation of investigations by regulatory bodies; substantial monetary awards to trial participants or patients; loss of revenue … investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; and other

6 Mar 25

4:25pm

CDTX Cidara Therapeutics, Inc.

Departure of Directors or Certain Officers

under the section of this Agreement entitled “Protected Rights”) assist any person in bringing or pursuing any proposed or pending litigation, arbitration

CDTX Cidara Therapeutics, Inc.

Departure of Directors or Certain Officers

litigation, arbitration, administrative claim or other formal proceeding against the Company, its parent or subsidiary entities, affiliates, officers

q9cv22h0ww8 jpe

Prospectus supplement

IPO registration

23 Dec 24

4:39pm

wxaqefs hj7wonfs9xp

Cidara Therapeutics Announces $105 Million Private Placement

Cidara Therapeutics Announces $105 Million Private Placement

Cidara Therapeutics Announces $105 Million Private Placement

Cidara Therapeutics Announces $105 Million Private Placement

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Quarterly report

7 Nov 24

4:08pm

Cost Associated with Exit or Disposal Activities

Registration of securities for employees

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Quarterly report

13 Aug 24

4:15pm

Quarterly report

13 Aug 24

4:15pm

IPO registration

19 Jul 24

4:54pm

Prev
1
2
3
4
5
...
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.